A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose
Completed · Phase 1 · Has a placebo group
Conditions studied: Diabetes
In brief
A Study to Assess the Effect of CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose in Obese Male Subjects and Subjects with T2DM.
Key facts
- Study ID
- NCT04973111
- Run by
- Carmot Therapeutics, Inc.
- People needed
- 32
- Starts
- 2021-07-16
- Expected to finish
- 2022-04-22
- Last updated by the study team
- 2025-03-28
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Part 1: Obese Otherwise Healthy Males
- Part 2: Males or Females with T2D
- Part 1: BMI 30.0-35.0, inclusive
- Part 2: BMI 27.0-45.0, inclusive
- 18-65 years old, inclusive
- Stable body weight for 2 months
You may not qualify if…
- Significant medical history
- Uncontrolled hypertension
- History of malignancy
Where it is running
- Carmot Clinical Research Unit 101 — Chula Vista, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.